Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 6
Merck Wants Vioxx MDL in Maryland Federal District Court
Court Denies Interlocutory Appeal of Decision Dismissing Pharmacist in Arava Case
Following Vioxx Recall, Plaintiff Wants Second Shot at Daubert Responses
Judge Adopts Recommendation Denying Merck Motion for Summary Judgment
N.Y. Man Links Irregular Heartbeat, Other Ills To Celebrex Cox-2 Painkiller
Plaintiffs Move to Create Federal MDL for Vioxx Lawsuits
N.Y. Plaintiffs Accuse Merck of Misleading Consumers About Vioxx Safety
Arthritis Drugs - Issue: 1
Judge Grants Plaintiffs' Unopposed Motion to Remand Remicade Injury Case
